• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Paediatric rheumatology in 2017: Child-centred research is the key to progress.

作者信息

Beresford Michael W, Ramanan Athimalaipet V

机构信息

Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust and at the Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Institute in the Park, Alder Hey Children's NHS Foundation Trust, East Prescott Road, Liverpool L14 5AB, UK.

Bristol Royal Hospital for Children and at the Bristol Medical School, University of Bristol, Upper Maudlin Street, Bristol BS2 8BJ, UK.

出版信息

Nat Rev Rheumatol. 2018 Feb;14(2):69-70. doi: 10.1038/nrrheum.2017.214. Epub 2018 Jan 11.

DOI:10.1038/nrrheum.2017.214
PMID:29323342
Abstract
摘要

相似文献

1
Paediatric rheumatology in 2017: Child-centred research is the key to progress.
Nat Rev Rheumatol. 2018 Feb;14(2):69-70. doi: 10.1038/nrrheum.2017.214. Epub 2018 Jan 11.
2
Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexate.多关节型幼年特发性关节炎患者接受阿达木单抗联合或不联合甲氨蝶呤治疗的长期结局。
RMD Open. 2020 Jul;6(2). doi: 10.1136/rmdopen-2020-001208.
3
Adalimumab versus adalimumab and methotrexate for the treatment of juvenile idiopathic arthritis: long-term data from the German BIKER registry.阿达木单抗对比阿达木单抗联合甲氨蝶呤治疗幼年特发性关节炎：来自德国BIKER注册研究的长期数据。
Scand J Rheumatol. 2019 Mar;48(2):95-104. doi: 10.1080/03009742.2018.1488182. Epub 2018 Nov 9.
4
A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial).阿达木单抗联合甲氨蝶呤治疗青少年特发性关节炎相关性葡萄膜炎的临床疗效、安全性及成本效益的随机对照试验（SYCAMORE试验）
Trials. 2014 Jan 9;15:14. doi: 10.1186/1745-6215-15-14.
5
Anti-adalimumab antibodies in juvenile idiopathic arthritis: frequent association with loss of response.青少年特发性关节炎中的抗阿达木单抗抗体：与反应丧失频繁相关。
Scand J Rheumatol. 2015;44(5):359-62. doi: 10.3109/03009742.2015.1022213. Epub 2015 May 14.
6
Anti-adalimumab antibodies kinetics: an early guide for juvenile idiopathic arthritis (JIA) switching.抗阿达木单抗抗体动力学：幼年特发性关节炎（JIA）转换的早期指导。
Clin Rheumatol. 2020 Feb;39(2):515-521. doi: 10.1007/s10067-019-04798-6. Epub 2019 Nov 9.
7
Cost-Effectiveness Analysis of Adalimumab for the Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis.阿达木单抗治疗幼年特发性关节炎相关葡萄膜炎的成本-效果分析。
Ophthalmology. 2019 Mar;126(3):415-424. doi: 10.1016/j.ophtha.2018.09.043. Epub 2018 Oct 16.
8
The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation.阿巴西普、阿达木单抗、依那西普和托珠单抗治疗幼年特发性关节炎的临床有效性和成本效益：一项系统评价和经济学评估
Health Technol Assess. 2016 Apr;20(34):1-222. doi: 10.3310/hta20340.
9
Comparative Effectiveness of Tumor Necrosis Factor Agents and Disease-modifying Antirheumatic Therapy in Children with Enthesitis-related Arthritis: The First Year after Diagnosis.肿瘤坏死因子制剂与疾病修饰抗风湿疗法在附着点相关关节炎儿童中的比较疗效：诊断后第一年。
J Rheumatol. 2018 Jan;45(1):107-114. doi: 10.3899/jrheum.170251. Epub 2017 Sep 15.
10
Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis.阿达木单抗联合甲氨蝶呤治疗幼年特发性关节炎相关葡萄膜炎。
N Engl J Med. 2017 Apr 27;376(17):1637-1646. doi: 10.1056/NEJMoa1614160.

本文引用的文献

1
Recommendations for collaborative paediatric research including biobanking in Europe: a Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) initiative.关于欧洲儿科研究（包括生物库）的合作建议：欧洲儿科风湿病学单一中心和访问点（SHARE）倡议。
Ann Rheum Dis. 2018 Mar;77(3):319-327. doi: 10.1136/annrheumdis-2017-211904. Epub 2017 Oct 11.
2
European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative.欧洲基于证据的儿童发病狼疮肾炎诊断和治疗推荐：SHARE 倡议。
Ann Rheum Dis. 2017 Dec;76(12):1965-1973. doi: 10.1136/annrheumdis-2017-211898. Epub 2017 Sep 6.
3
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both.
用于研究多种疗法、多种疾病或两者兼有的主方案。
N Engl J Med. 2017 Jul 6;377(1):62-70. doi: 10.1056/NEJMra1510062.
4
European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative.欧洲基于证据的儿童发病系统性红斑狼疮诊断和治疗推荐：SHARE 倡议。
Ann Rheum Dis. 2017 Nov;76(11):1788-1796. doi: 10.1136/annrheumdis-2016-210960. Epub 2017 Jun 19.
5
European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative.欧洲基于证据的儿科抗磷脂综合征诊断和治疗建议：SHARE 倡议。
Ann Rheum Dis. 2017 Oct;76(10):1637-1641. doi: 10.1136/annrheumdis-2016-211001. Epub 2017 May 4.
6
Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis.阿达木单抗联合甲氨蝶呤治疗幼年特发性关节炎相关葡萄膜炎。
N Engl J Med. 2017 Apr 27;376(17):1637-1646. doi: 10.1056/NEJMoa1614160.
7
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications.遗传结构将全身型幼年特发性关节炎与其他类型的幼年特发性关节炎区分开来：临床及治疗意义
Ann Rheum Dis. 2017 May;76(5):906-913. doi: 10.1136/annrheumdis-2016-210324. Epub 2016 Dec 7.
8
Consensus-based recommendations for the management of juvenile dermatomyositis.基于共识的青少年皮肌炎管理建议。
Ann Rheum Dis. 2017 Feb;76(2):329-340. doi: 10.1136/annrheumdis-2016-209247. Epub 2016 Aug 11.
9
Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis.免疫相关疾病区域的高密度基因分型鉴定出青少年特发性关节炎的 14 个新易感位点。
Nat Genet. 2013 Jun;45(6):664-9. doi: 10.1038/ng.2614. Epub 2013 Apr 21.